Episode Details
Back to Episodes
Abivax Stock Soars on Safety Data | Business and Finance News
Published 2 days, 9 hours ago
Description
Abivax stock soars 30% after revealing ulcerative colitis trial data showing cancer rates aligned with expectations—boosting confidence in obefazimod’s safety and long-term potential.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/70fe009789cfcf12